Published in Exp Ther Med on February 20, 2014
Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care (2007) 29.89
The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med (1994) 27.68
A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA (2000) 4.92
Sepsis syndrome: a valid clinical entity. Methylprednisolone Severe Sepsis Study Group. Crit Care Med (1989) 3.41
Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients. Am J Med (1980) 3.03
Hypothermia in the sepsis syndrome and clinical outcome. The Methylprednisolone Severe Sepsis Study Group. Crit Care Med (1992) 2.99
Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology. Clin Sci (Lond) (2007) 2.39
Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-alpha, and interferon-gamma in the serum of patients with septic shock. Swiss-Dutch J5 Immunoglobulin Study Group. J Infect Dis (1990) 2.36
Inflammation and angiotensin II. Int J Biochem Cell Biol (2003) 2.22
Impact of encephalopathy on mortality in the sepsis syndrome. The Veterans Administration Systemic Sepsis Cooperative Study Group. Crit Care Med (1990) 2.04
Mitochondrial dysfunction in septic shock and multiple organ dysfunction syndrome. Mitochondrion (2004) 1.56
Antagonist of the type-1 ANG II receptor prevents against LPS-induced septic shock in rats. Intensive Care Med (2009) 1.02
Prediction of patient outcome from Acinetobacter baumannii bacteremia with Sequential Organ Failure Assessment (SOFA) and Acute Physiology and Chronic Health Evaluation (APACHE) II scores. Intern Med (2011) 1.00
Angiotensin II in experimental hyperdynamic sepsis. Crit Care (2009) 0.98
Effects of the angiotensin-converting enzyme inhibitor perindopril on endothelial injury and hemostasis in rabbit endotoxic shock. Intensive Care Med (2004) 0.93
Modulation of the renin-angiotensin-aldosterone system in sepsis: a new therapeutic approach? Expert Opin Ther Targets (2010) 0.93
The Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Resusc (2008) 0.92
A critical evaluation of new agents for the treatment of sepsis. JAMA (1991) 0.92
Role of angiotensin II in endothelial dysfunction induced by lipopolysaccharide in mice. Am J Physiol Heart Circ Physiol (2007) 0.89
Angiotensin for septic shock unresponsive to noradrenaline. Arch Dis Child (2000) 0.88
Nitric oxide-dependent down-regulation of angiotensin II type 2 receptors during experimental sepsis. Crit Care Med (2001) 0.86
Losartan attenuates ventilator-induced lung injury. J Surg Res (2007) 0.85
Blockade of multiple but not single cytokines abrogates downregulation of angiotensin II type-I receptors and anticipates septic shock. Cytokine (2009) 0.82
Erythropoietin and renin as biological markers in critically ill patients. Crit Care (2004) 0.82
Escherichia coli lipopolysaccharide inhibits renin activity in human mesangial cells. Kidney Int (2006) 0.82
Losartan to prevent hyperenzymemia after endoscopic retrograde cholangiopan-creatography: A randomized clinical trial. World J Gastrointest Endosc (2012) 0.79
Role of regulatory peptide in pathogenesis of shock. Sci China B (1994) 0.78
[Validity of APACHE II, APACHE III, SAPS 2, SAPS 3 and SOFA scales in obstetric patients with sepsis]. Anesteziol Reanimatol (2013) 0.77
Role of angiotensin II in neonatal sepsis. Circ Shock (1993) 0.77
Enalapril does not alter adhesion molecule levels in human endotoxemia. Shock (2003) 0.77